+1 858-523-8231
Login | Register
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
Home Other Building Blocks 18621-17-5
18621-17-5,MFCD20705804
Catalog No.:AA003D0F

18621-17-5 | 1-Benzhydrylazetidin-3-ol

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$6.00   $4.00
- +
5g
98%
in stock  
$6.00   $4.00
- +
10g
98%
in stock  
$8.00   $5.00
- +
25g
98%
in stock  
$12.00   $8.00
- +
100g
95%
in stock  
$23.00   $16.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA003D0F
Chemical Name:
1-Benzhydrylazetidin-3-ol
CAS Number:
18621-17-5
Molecular Formula:
C16H17NO
Molecular Weight:
239.3123
MDL Number:
MFCD20705804
SMILES:
OC1CN(C1)C(c1ccccc1)c1ccccc1
NSC Number:
319045
Properties
Properties
 
BP:
353.8°C at 760 mmHg  
Form:
Solid  
MP:
106 °C  
Storage:
Keep in dry area;Room Temperature;  

Computed Properties
 
Complexity:
232  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
18  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
3  
XLogP3:
2.6  

Upstream Synthesis Route

[1]BioorganicandMedicinalChemistryLetters,2011,vol.21,#20,p.6031-6035

[2]Patent:EP1889836,2008,A1,

[1]OrganicProcessResearchandDevelopment,2012,vol.16,#5,p.788-797

[2]Patent:US2010/69351,2010,A1,.Locationinpatent:Page/Pagecolumn42

[3]Patent:WO2011/61214,2011,A1,.Locationinpatent:Page/Pagecolumn151

[4]Patent:WO2008/55959,2008,A1,.Locationinpatent:Page/Pagecolumn106

[5]Patent:WO2004/24730,2004,A1,.Locationinpatent:Page46

[6]Patent:CN106905212,2017,A,.Locationinpatent:Paragraph0013;0014-0015

[7]Patent:EP1213289,2002,A1,.Locationinpatent:Page11

[8]Patent:WO2005/54184,2005,A1,.Locationinpatent:Page/Pagecolumn8-9

[9]Patent:US2004/157839,2004,A1,.Locationinpatent:Page28

[10]Patent:US2004/214837,2004,A1,.Locationinpatent:Page27-28

[11]Patent:WO2006/72353,2006,A1,.Locationinpatent:Page/Pagecolumn47-48

[12]ChemicalandPharmaceuticalBulletin,1995,vol.43,#5,p.797-817

[13]Tetrahedron,2006,vol.62,#29,p.6869-6875

[14]Patent:WO2007/60526,2007,A1,.Locationinpatent:Page/Pagecolumn42;66

[15]JournalofHeterocyclicChemistry,1994,vol.31,#2,p.271-276

[16]Patent:EP1621537,2006,A1,.Locationinpatent:Page/Pagecolumn48

[17]Patent:EP1591443,2005,A1,.Locationinpatent:Page/Pagecolumn65-66

[18]BioorganicandMedicinalChemistryLetters,2003,vol.13,#13,p.2191-2194

[19]Patent:WO2004/112793,2004,A1,.Locationinpatent:Page/Pagecolumn126-127

[20]Patent:US5510362,1996,A,

[21]Patent:US5567726,1996,A,

[22]Patent:US2008/312209,2008,A1,.Locationinpatent:Page/Pagecolumn19

[23]Patent:WO2007/7018,2007,A1,.Locationinpatent:Page/Pagecolumn56

[24]Patent:EP1757582,2007,A1,.Locationinpatent:Page/Pagecolumn34-35

[25]Patent:WO2006/136830,2006,A1,.Locationinpatent:Page/Pagecolumn194-195

[1]Patent:EP1762568,2007,A1,.Locationinpatent:Page/Pagecolumn37

[1]Patent:US6140347,2000,A,

[1]Patent:WO2013/14448,2013,A1,.Locationinpatent:Page/Pagecolumn96

[2]MedicinalChemistryResearch,2013,vol.22,#12,p.5982-5989

[3]Patent:US2003/229226,2003,A1,.Locationinpatent:Page21-22

[4]Synthesis(Germany),2018,vol.50,#5,p.1020-1026

Downstream Synthesis Route

[1]Patent:CN110551133,2019,A.Locationinpatent:Paragraph0006;0013

[2]OrganicProcessResearchandDevelopment,2012,vol.16,p.788-797

[3]Patent:US2010/69351,2010,A1.Locationinpatent:Page/Pagecolumn42

[4]Patent:WO2011/61214,2011,A1.Locationinpatent:Page/Pagecolumn151

[5]Patent:WO2008/55959,2008,A1.Locationinpatent:Page/Pagecolumn106

[6]Patent:WO2004/24730,2004,A1.Locationinpatent:Page46

[7]Patent:CN106905212,2017,A.Locationinpatent:Paragraph0013;0014-0015

[8]Patent:EP1213289,2002,A1.Locationinpatent:Page11

[9]Patent:WO2005/54184,2005,A1.Locationinpatent:Page/Pagecolumn8-9

[10]Patent:US2004/157839,2004,A1.Locationinpatent:Page28

[11]Patent:US2004/214837,2004,A1.Locationinpatent:Page27-28

[12]Patent:WO2006/72353,2006,A1.Locationinpatent:Page/Pagecolumn47-48

[13]ChemicalandPharmaceuticalBulletin,1995,vol.43,p.797-817

[14]Tetrahedron,2006,vol.62,p.6869-6875

[15]Patent:WO2007/60526,2007,A1.Locationinpatent:Page/Pagecolumn42;66

[16]JournalofHeterocyclicChemistry,1994,vol.31,p.271-276

[17]Patent:EP1621537,2006,A1.Locationinpatent:Page/Pagecolumn48

[18]Patent:EP1591443,2005,A1.Locationinpatent:Page/Pagecolumn65-66

[19]BioorganicandMedicinalChemistryLetters,2003,vol.13,p.2191-2194

[20]Patent:WO2004/112793,2004,A1.Locationinpatent:Page/Pagecolumn126-127

[21]Patent:US5510362,1996,A

[22]Patent:US5567726,1996,A

[23]Patent:US2008/312209,2008,A1.Locationinpatent:Page/Pagecolumn19

[24]Patent:WO2007/7018,2007,A1.Locationinpatent:Page/Pagecolumn56

[25]Patent:EP1757582,2007,A1.Locationinpatent:Page/Pagecolumn34-35

[26]Patent:WO2006/136830,2006,A1.Locationinpatent:Page/Pagecolumn194-195

[27]Patent:WO2020/58913,2020,A1.Locationinpatent:Page/Pagecolumn68-69

[1]Patent:US2005/54697,2005,A1.Locationinpatent:Page/Pagecolumn78

[2]BioorganicandMedicinalChemistryLetters,2009,vol.19,p.1084-1088

[3]Patent:WO2011/61214,2011,A1.Locationinpatent:Page/Pagecolumn85-86

[4]Patent:US2014/288045,2014,A1.Locationinpatent:Paragraph0605

[5]Patent:WO2016/44772,2016,A1.Locationinpatent:Paragraph319

[6]Patent:US2016/207883,2016,A1.Locationinpatent:Paragraph0394-0396

[7]Patent:WO2019/238633,2019,A1.Locationinpatent:Page/Pagecolumn129

[8]Patent:WO2013/14448,2013,A1.Locationinpatent:Page/Pagecolumn95;96

[9]JournalofOrganicChemistry,2019,vol.84,p.1363-1371

[10]Patent:WO2016/30310,2016,A1.Locationinpatent:Page/Pagecolumn49

[11]Patent:WO2013/10453,2013,A1.Locationinpatent:Page/Pagecolumn135

[12]MedicinalChemistryResearch,2013,vol.22,p.5982-5989

[13]JournalofChemicalResearch-PartS,1996,p.430-431

[14]Patent:WO2006/72353,2006,A1.Locationinpatent:Page/Pagecolumn51-52

[15]Patent:WO2012/101654,2012,A2.Locationinpatent:Page/Pagecolumn63

[16]Patent:EP1889836,2008,A1.Locationinpatent:Page/Pagecolumn79

[17]Patent:US2008/214815,2008,A1.Locationinpatent:Page/Pagecolumn13-14

[18]Patent:EP2119706,2009,A1.Locationinpatent:Page/Pagecolumn47-48

[19]JournalofOrganicChemistry,1991,vol.56,p.6729-6730

[20]JournalofMedicinalChemistry,1993,vol.36,p.801-810

[21]JournalofChemicalResearch,2006,p.478-480

[22]Patent:US2001/27193,2001,A1

[23]Patent:US5846965,1998,A

[24]Patent:US6242438,2001,B1

[25]Patent:US6262075,2001,B1

[26]Patent:WO2007/26207,2007,A1.Locationinpatent:Page/Pagecolumn3

[27]Patent:EP1813610,2007,A1.Locationinpatent:Page/Pagecolumn10

[28]Patent:US2007/254892,2007,A1.Locationinpatent:Page/Pagecolumn38

[29]Patent:EP1918284,2008,A1.Locationinpatent:Page/Pagecolumn33

[30]Patent:WO2008/60767,2008,A2.Locationinpatent:Page/Pagecolumn122-123

[31]Patent:US2009/233904,2009,A1.Locationinpatent:Page/Pagecolumn78

[32]BioorganicandMedicinalChemistryLetters,2009,vol.19,p.1517-1521

[33]Patent:US2010/249399,2010,A1.Locationinpatent:Page/Pagecolumn21

[34]BioorganicandMedicinalChemistryLetters,2011,vol.21,p.6031-6035

[35]Patent:WO2012/76063,2012,A1.Locationinpatent:Page/Pagecolumn44-45

[36]OrganicProcessResearchandDevelopment,2012,vol.16,p.788-797

[37]Patent:US2013/261100,2013,A1.Locationinpatent:Paragraph0314-0315

[38]OrganicLetters,2014,vol.16,p.2744-2747

[39]Patent:EP2805946,2014,A1.Locationinpatent:Paragraph0115;0116

[40]Patent:US2014/357613,2014,A1.Locationinpatent:Paragraph0151;0152

[41]Patent:WO2008/107368,2008,A1.Locationinpatent:Page/Pagecolumn40

[42]Patent:WO2019/118612,2019,A1.Locationinpatent:Paragraph0226

[1]Patent:CN106543061,2017,A.Locationinpatent:Paragraph0022;0023;0024;0025;0026

[2]Patent:US2013/85127,2013,A1.Locationinpatent:Paragraph0373;0374;0375;0376

[3]Patent:US2004/9965,2004,A1

[4]JournalofOrganicChemistry,1991,vol.56,p.6729-6730

[5]Patent:EP3248980,2017,A1.Locationinpatent:Paragraph0289;0290;0291

[6]Patent:EP1213289,2002,A1.Locationinpatent:Page11

[7]Patent:WO2012/101654,2012,A2.Locationinpatent:Page/Pagecolumn63

[8]Patent:WO2008/108988,2008,A1.Locationinpatent:Page/Pagecolumn70

[9]ChemicalandPharmaceuticalBulletin,1995,vol.43,p.797-817

[10]Patent:US5968923,1999,A

[11]Patent:US5741790,1998,A

[12]Patent:US5846965,1998,A

[13]Patent:US4183923,1980,A

[14]Patent:US6242438,2001,B1

[15]Patent:US6262075,2001,B1

[16]Patent:US5510362,1996,A

[17]Heterocycles,2008,vol.75,p.2981-2988

[18]BioorganicandMedicinalChemistryLetters,2011,vol.21,p.6031-6035

[19]OrganicLetters,2014,vol.16,p.2744-2747

[1]Patent:WO2007/118830,2007,A1.Locationinpatent:Page/Pagecolumn91

[1]Frigola;Pares;Corbera;Vano;Merce;Torrens;Mas;Valenti[JournalofMedicinalChemistry,1993,vol.36,#7,p.801-810]

Literature
Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 18621-17-5
90604-02-7

90604-02-7

 27159-32-6

27159-32-6

 107128-00-7

107128-00-7

 54881-13-9

54881-13-9

 89448-83-9

89448-83-9

 80548-31-8

80548-31-8
Building Blocks
More >
Tags:18621-17-5 Molecular Formula|18621-17-5 MDL|18621-17-5 SMILES|18621-17-5 1-Benzhydrylazetidin-3-ol |Organic_Building_Blocks